Cargando…
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
BACKGROUND: Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. OBJECTIVE: We set-up a multicenter Italian collaboration to investigate the relationship between HCQ therapy and COVID-19 in-hospital mortality. METHODS: In a retrospective observational study, 3,451 unselected pa...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446618/ https://www.ncbi.nlm.nih.gov/pubmed/32859477 http://dx.doi.org/10.1016/j.ejim.2020.08.019 |
Ejemplares similares
-
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study
por: Di Castelnuovo, Augusto, et al.
Publicado: (2021) -
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study
por: Di Castelnuovo, Augusto, et al.
Publicado: (2020) -
Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study
por: Kalligeros, Markos, et al.
Publicado: (2020) -
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
por: Ageno, Walter, et al.
Publicado: (2021) -
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
por: Catteau, Lucy, et al.
Publicado: (2020)